SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 237.01 |
| Enterprise Value ($M) | 164.44 |
| Book Value ($M) | 34.53 |
| Book Value / Share | 0.82 |
| Price / Book | 6.86 |
| NCAV ($M) | -45.07 |
| NCAV / Share | -1.07 |
| Price / NCAV | -5.26 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -1.26 |
| Return on Assets (ROA) | -0.23 |
| Return on Equity (ROE) | -0.61 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | n/a |
| Current Ratio | 11.27 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 167.28 |
| Assets | 246.89 |
| Liabilities | 212.35 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -90.14 |
| Net Income | -82.37 |
| Earnings Per Share Basic And Diluted | -1.03 |
| Earnings Per Share Diluted | -1.03 |
| Earnings Per Share Basic | -1.03 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -65.51 |
| Cash from Investing | -1.76 |
| Cash from Financing | -1.76 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| Quarterly Report – 10-Q | ||
| Quarterly Report – 10-Q | ||
| Annual Report – 10-K | ||
(click for more detail) |
||
| Similar Companies | |
|---|---|
| ABCL – AbCellera Biologics Inc. | ABEO – Abeona Therapeutics Inc. |
| ABIO – ARCA biopharma, Inc. | ABUS – Arbutus Biopharma Corporation |
| ACAD – ACADIA Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io